NS · Healthcare

Mercury Laboratories Ltd (538964)

Pharmaceuticals & Biotechnology

Mercury Laboratories Ltd (538964) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $984.00M, P/E ratio is 20.36, net margin is 5.9%, dividend yield is 0.43%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 538964

Market cap

$984.00M

P/E ratio

20.36

Net margin

5.9%

Dividend yield

0.43%

Mercury Laboratories Ltd (538964) — FAQ

What is Mercury Laboratories Ltd's market cap?

Mercury Laboratories Ltd (538964) has a reported market cap of $984.00M (data as of 2026-07-10).

What is 538964's P/E ratio?

The price-to-earnings (P/E) ratio for Mercury Laboratories Ltd (538964) is 20.36 (data as of 2026-07-10).

Does Mercury Laboratories Ltd pay a dividend?

Mercury Laboratories Ltd (538964) shows a reported dividend yield of 0.43%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Mercury Laboratories Ltd in?

Mercury Laboratories Ltd (538964) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 538964 listed on?

538964 is listed on NS.

What is Mercury Laboratories Ltd's net margin?

Mercury Laboratories Ltd (538964) reports a net margin of 5.9% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)